Maynard Um
-
-
-
-
-
-
-
RBC Capital maintains Outperform rating on Insmed amid CFO change
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Insmed (INSM) Ahead of Q2 Results
-
-
-
-
-
-
-
Insmed (INSM) PT Lowered to $192 at Mizuho
-
-
-
-
-
-
-
Buy the dip in this stock after a 23% earnings drop: Wall Street
-
-
-
-
-
-
-
Insmed (INSM) PT Lowered to $220 at H.C. Wainwright
-
-
-
-
-
-
-
Jefferies on Insmed (INSM): UTHR data 'validates inhaled prostacyclin class in IPF,' INSM's TPIP potl BIC
-
-
-
-
-
-
-
Insmed (INSM) PT Raised to $203 at RBC Capital
-
470,348 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


